医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Novo Nordisk Thailand Achieves the Best Place To Work Certification for the Second Consecutive Year

2021年10月05日 AM09:00
このエントリーをはてなブックマークに追加


 

BANGKOK

Novo Nordisk Thailand, an affiliate of the global healthcare company with more than 95 years of innovation and leadership in diabetes care, has been recognized as one of the best companies to work in Thailand both in 2020 and 2021. The company offers an award-winning culture, advancement opportunities, career training and development, high-level mentoring, mental and physical wellness initiatives, environmental and social initiatives, and competitive benefits resulting in its recognition among the employers of choice in Thailand. According to the company results, 99% of the employees said it’s a great workplace compared to 82% in a typical Thai organization.

“Novo Nordisk Thailand prioritize all employees and their families during this ongoing pandemic with clear communication in terms of health, safety and environment. Timely engagement while working from home are being organized in a lively manner. The focus on its employee well-being is highly commendable and appreciated during this period. The team spirit never fails in ensuring all hurdles are managed together accordingly and celebration of successes throughout the year” said one of the Novo Nordisk Thailand employee’s interviewed.

“We’re honoured to be among the best companies to work for in Thailand for 2 consecutive years” said John Dawber, Novo Nordisk’s General Manager for Thailand. “I am truly humbled by the results, given that we are a best place to work in Thailand for 2 consecutive years, particularly during the COVID-19 pandemic. We work hard, whilst taking a systematic approach to acting upon feedback to ensure that the environment we provide is one where all our people can enjoy, feel safe, included and be successful. Even during work from home period, we pay closer attention to our teams’ individual circumstances, and create the work environment that is best for our employees in difficult situations.”

“The feedback received from last year Best Place To Work Award, was used to further improve, to meet with our employee needs. We are particularly pleased that we were able to improve all the scores across the 8 dimensions of the survey, compared with 2020. The key to success of our company is our employees. We thank them for their immense contribution to our company culture, for their trust in our mission, and their honest feedback” said Vera Bakirova, HR Director for Novo Nordisk Thailand.

“Despite the difficulties brought by the pandemic, Novo Nordisk Thailand has not only been able to deliver outstanding business results, and make positive contributions to the society and the environment, they as well as earn the trust of their employees to continue being one of the Best Places To Work in Thailand”

ABOUT BEST PLACES TO WORK PROGRAM

Best Places To Work is a global certification program that recognizes leading workplaces in many countries around the world. Our proprietary assessment analyzes a company’s attractiveness through a two-step process focusing on 8 Workplace factors including culture, leadership, opportunities for growth and people practices. Beside the employee satisfaction survey, we conduct an HR assessment focusing on HR practices implemented in the organization against our people framework standard proven to deliver market-leading revenue and increased innovation.

For more information, please visit www.bestplacestoworkfor.org

View source version on businesswire.com: https://www.businesswire.com/news/home/20211004005824/en/

CONTACT

Press: Grace Kelly

Email: grace@bestplacestoworkinasia.com

Tel: +65 3159 1167

同じカテゴリーの記事 

  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表
  • The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report
  • Masimo创始人兼首席执行官Joe Kiani将在智利举行的全球患者安全峰会上谈论人工智能
  • マシモ創業者兼最高経営責任者(CEO)のジョー・キアニがチリで開催される世界患者安全サミットでAIについて講演
  • Codone Biotech to Present Data on its Suppressor-tRNA Platform in Disease Models with Nonsense Mutations (Premature Termination Codons)